Speaking at the Deutsche Bank Technology Conference last week, Salesforce deputy CFO and head of finance Mike Spencer said the company's extensive use of Claude tokens in its R&D cycle had prevented it from raising margin guidance for the year. "Roughly about six months ago we unleashed Claude in our R&D cycle. It's part of the reason we didn't raise margin guidance on the year because we're covering some of the token spend that we've got going," Spencer said. "And the goal of that really was to, let's see what we could break. Let's see what kind of advancement our R&D teams can make on accelerating the product road map. Worst-case scenario, we would pull back."
Salesforce is now moving to what Spencer called "refinement mode" — selecting the most cost-effective AI model for each task rather than always using the most advanced one. "We're going into the zone of 'prescription model choice for task at hand,' and what that really means is you don't need to use the latest and greatest model for every single task you might want to do," he said. Spencer noted that the company is experimenting with models from multiple vendors, including OpenAI, Cursor, Claude, and X's Grok, each with different cost structures.
The spending with Anthropic is substantial. In May, Salesforce CEO Marc Benioff said the company expected to spend $300 million with the Claude maker in 2026. Salesforce is not alone in seeking to optimise AI spending: Cockroach Labs CEO Spencer Kimball told The Register in June that his company was turning to open-source models to control costs, while Gartner has warned that the cost of coding agents could soon exceed developer salaries in some regions.